Related Experiment Video
Updated: May 4, 2026

04:04
Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
Published on: July 11, 2025
2.2K
Caloric vestibular stimulation in aphasic syndrome
David Wilkinson1, Rachael Morris1, William Milberg2
1School of Psychology, University of Kent Canterbury, Kent, UK.
Frontiers in Integrative Neuroscience
|January 7, 2014
Summary
Caloric vestibular stimulation (CVS) may help improve language and communication symptoms in post-stroke aphasia patients. Two of three participants showed significant naming improvements after four weeks of daily CVS treatment.
Area of Science:
- Neuroscience
- Neurology
- Speech and Language Pathology
Background:
- Caloric vestibular stimulation (CVS) is a diagnostic tool for brainstem disorders.
- Its therapeutic potential, particularly for neurological communication deficits, is less understood.
- Previous research suggests CVS can increase blood flow to language-associated brain regions.
Purpose of the Study:
- To investigate the potential of CVS as a therapeutic intervention for post-stroke aphasia.
- To assess the effects of CVS on expressive and receptive language symptoms.
Main Methods:
- Three participants with chronic, left-hemisphere stroke-related aphasia received daily CVS for four weeks.
- Language function was assessed using picture naming, responsive naming, sentence repetition, and auditory word discrimination tasks.
- Performance was compared to pre-treatment baseline scores and evaluated at immediate and 1-week follow-up.
Main Results:
- Two out of three participants demonstrated significant improvements in picture and responsive naming.
- One participant showed enhanced sentence repetition abilities.
- Another participant exhibited improved auditory word discrimination.
- No adverse effects were reported during the study.
Conclusions:
- Caloric vestibular stimulation shows tentative promise for alleviating both expressive and receptive aphasia symptoms.
- These findings suggest CVS may be a viable therapeutic option for stroke survivors with aphasia.
- Further investigation through larger, sham-controlled trials is warranted to confirm efficacy.

